Post-IPO Equity - Yield10 Bioscience
Investment Firm
Overview
Yield10 Bioscience develops crop yield improvement solutions using advanced genetic engineering and synthetic biology techniques.
Announced Date
Aug 28, 2020
Funding Type
Post Ipo Equity
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
1
| Investor Name |
|---|
 Jack Schuler |
Round Details and Background
Yield10 Bioscience raised $4000000 on 2020-08-28 in Post-IPO Equity
Yield10 Bioscience develops crop yield improvement solutions using advanced genetic engineering and synthetic biology techniques.
Company Funding History
8
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Aug 11, 2023 |  Post-IPO Equity - Yield10 Bioscience | - | 3.7M | |
| Jan 01, 2000 | Venture Round - Yield10 Bioscience | - | 10.8M | |
| Aug 04, 2014 | Post-IPO Equity - Yield10 Bioscience | 2 | - | 25.0M |
| May 05, 2011 | Grant - Yield10 Bioscience | 2 | - | 6.0M |
Recent Activity
There is no recent news or activity for this profile.